| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 60.705 | 73.468 | 128.740 | 141.988 | 175.267 | 172.736 | 245.832 | 280.729 | 306.865 | 355.580 |
| Total Income - EUR | 63.029 | 75.147 | 140.658 | 144.020 | 181.866 | 185.942 | 248.597 | 291.337 | 326.642 | 385.185 |
| Total Expenses - EUR | 39.204 | 43.610 | 52.145 | 65.640 | 70.742 | 70.818 | 88.319 | 108.608 | 128.393 | 177.603 |
| Gross Profit/Loss - EUR | 23.825 | 31.537 | 88.513 | 78.380 | 111.124 | 115.124 | 160.278 | 182.729 | 198.248 | 207.581 |
| Net Profit/Loss - EUR | 21.942 | 30.039 | 87.110 | 76.948 | 109.308 | 113.399 | 158.017 | 179.885 | 195.432 | 196.921 |
| Employees | 2 | 4 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 4 |
Check the financial reports for the company - Dermatop Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.713 | 5.092 | 47.908 | 36.607 | 27.314 | 24.492 | 16.570 | 12.314 | 205.866 | 201.406 |
| Current Assets | 53.677 | 63.823 | 105.555 | 145.221 | 221.301 | 269.740 | 345.663 | 181.006 | 300.950 | 384.398 |
| Inventories | 49 | 320 | 251 | 38 | 690 | 946 | 662 | 2.296 | 5.948 | 6.166 |
| Receivables | 457 | 2.012 | 39.843 | 31.399 | 8.009 | 12.625 | 12.834 | 12.086 | 198.830 | 13.649 |
| Cash | 5.843 | 2.315 | 6.457 | 54.569 | 54.808 | 94.237 | 174.480 | 46.258 | 22.120 | 275.128 |
| Shareholders Funds | 55.018 | 61.057 | 135.612 | 164.533 | 245.819 | 290.220 | 353.155 | 179.958 | 277.556 | 196.993 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 3.406 | 7.908 | 18.161 | 17.609 | 4.277 | 5.953 | 10.574 | 15.442 | 49.618 | 232.840 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 183.535 | 159.914 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dermatop Srl